Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rigerna Therapeutics Co., Ltd.

Clinical trials sponsored by Rigerna Therapeutics Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New kidney drug trial aims to find safe doses for patients Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New injection aims to slow kidney damage in IgA nephropathy

Disease control Recruiting now

This study tests an experimental drug called RG002C0106 in 30 adults with IgA nephropathy, a kidney disease. The goal is to see if the drug safely reduces protein in urine, a sign of kidney damage. Participants receive either the drug or a placebo, and neither they nor their doct…

Phase 2 • Sponsor: Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC